Cynthia Hawks

9PUBLICATIONS
15CO-AUTHORS
Biomedical imagingCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersInnate immunityCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 12, 2026
SUBDUE-3: SUB-urothelial DUrvalumab-<sup>89</sup>zirconium injEction; a phase 0 biodistribution study protocol.

Kevin G Keane, Richard Gauci, Roslyn J Francis

|Oct 28, 2025
G-DISCO: Gemcitabine-Docetaxel Intravesical Synchronous CO-administration - a phase 1 study protocol.

Kevin G Keane, Cynthia Hawks, Steve P McCombie

|Oct 16, 2024
Development of a new radical cystectomy surveillance protocol and nurse-led cystectomy follow-up clinic in Australia.

Ashley Lee, Katherine Ong, Mohammed Al-Zubaidi

|Mar 12, 2024
The SUB-urothelial DUrvalumab InjEction-1 (SUBDUE-1) trial: first-in-human trial in patients with bladder cancer.

Dickon Hayne, Katherine Ong, Nicole Swarbrick

|Mar 03, 2023
Lymph node assessment technique matters in radical cystectomy for bladder cancer.

Matthew Chau, Ivan Thia, Pravin Viswambaram

|Jul 26, 2021
Nurse-led telephone notification of a prostate cancer diagnosis: Prospective analysis of men's preferences for and experiences of a same-day assessment and diagnostic clinic.

Cynthia Hawks, Pravin Viswambaram, Claire Cloney

Pageof 2

Frequent Collaborators

9 joint publications

Dickon Hayne

2 joint publications

Steve P McCombie

2 joint publications

Pravin Viswambaram

1 joint publications

Bradley R Reynolds